NeuroOne Medical Chief Business Officer David J. Wambeke acquires 33,333 common shares worth $66,999.33
NMTC•Insider share purchase and option grant
NeuroOne Medical Technologies Chief Business Officer David J. Wambeke bought 33,333 common shares at $2.01 each.
Direct holdings rose to 199,999 common shares following the purchase.
He also received options for 35,000 shares at a $1.77 exercise price.
